Whalesbook
Liver Disease's Expanding Reach
Care Health Insurance reports a dramatic rise in liver disease claims, which have doubled over the past three years. Treatment expenses have also surged by nearly 100%. This alarming trend is driven by more people getting liver diseases, delayed diagnoses, and more complex treatments. Cases among younger policyholders are increasing by 5-10% annually, while claims from Tier 2 and Tier 3 cities are growing faster at 10-15% each year. This indicates that liver issues are spreading beyond major metropolitan areas. Claims involving women are also rising by about 10% annually. The Ministry of Health and Family Welfare estimates that Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), formerly known as Non-Alcoholic Fatty Liver Disease (NAFLD), affects between 9% and 32% of the Indian population. This is largely due to lifestyle factors like obesity and sedentary habits, which can lead to silent progression and higher treatment costs upon diagnosis.
Insurance Coverage Falling Short
This changing disease pattern is challenging the adequacy of current health insurance coverage levels. A sum insured of ₹5 lakh, once considered standard, is frequently insufficient, as major liver disease treatments can easily exceed ₹10 lakh. Some analyses suggest that a baseline cover of ₹15 lakh, combined with top-up plans, is becoming necessary. While health insurance sum insured levels in India have grown significantly over the years, the rapid increase in costs for specific chronic conditions like liver disease is outpacing general medical inflation. Underwriting MASLD poses further difficulties, as it is often considered a pre-existing condition, potentially involving waiting periods of two to three years before claims are covered.
Insurers Adapt with New Products and Wellness
Insurers are increasingly adopting a more proactive stance, incorporating preventive care and wellness programs. This includes offering regular health check-ups and early diagnostics for conditions such as diabetes, hypertension, and fatty liver, aiming to allow for earlier intervention and reduce long-term costs. Several insurers are developing specialized products for chronic conditions like diabetes and heart ailments, which bundle diagnostics, consultations, and wellness benefits. The health insurance market is also seeing growth in holistic health management, with insurers introducing wellness-linked products that reward policyholders for maintaining healthy habits. These often include incentives like premium discounts, reward points, and access to teleconsultations and dietary advice. Standalone health insurers are particularly focused on updating their product offerings and enhancing digital services.
Industry Risks and Financial Strain
The growing prevalence of lifestyle-driven diseases like MASLD presents significant risk for health insurers when predicting future claims. These conditions, often developing silently and linked to metabolic syndrome, obesity, and sedentary lifestyles, are becoming a major cause of death in India, accounting for approximately 63% of fatalities. This trend, worsened by urbanization and changing diets, leads to more frequent and costly claims, as chronic diseases require long-term management and often result in severe complications. For people with non-communicable diseases (NCDs), hospitalisation costs are much higher. When insurance is insufficient, people often pay a large part themselves, leading to financial hardship. Insurers struggle to price these risks correctly because standard underwriting methods may not fully account for how MASLD develops over time. A key concern is adverse selection: in a market with relatively low insurance penetration, individuals at higher risk may be more likely to buy policies only when they start showing symptoms. Average claim payouts in India are expected to jump by about 30% between FY23 and FY25, fueled by medical inflation and more chronic illnesses. This combination of rising medical costs (estimated at 12-14% annually) and increased chronic disease incidence strains premium pricing. It can also affect the incurred claims ratio (ICR), which is the amount insurers pay out in claims versus premiums earned. For instance, standalone health insurers had a lower ICR of 68.73% compared to public sector insurers (100.59%) and private general insurers (87.59%) in FY24-25. This indicates a wider gap between premiums collected and claims paid. Insurer profits could suffer if premiums don't keep pace with claim costs.
Future Projections for Liver Disease and Insurance
Long-term forecasts suggest a continued increase in the burden of liver disease. The World Obesity Federation estimates that approximately 1.19 crore Indian children could be living with liver disease by 2040 if current trends continue. The combination of rising incidence, expanding demographics, and higher treatment costs requires a fundamental shift in health insurance. The focus is gradually moving from just hospitalisation cover to a more comprehensive approach that includes prevention, early detection, and adequate financial protection to manage the challenges posed by non-communicable diseases. The Indian health insurance market is projected to reach USD 62 billion by 2033, growing at a compound annual growth rate of around 16.3%, indicating significant opportunity but also highlighting the urgent need for insurers to adapt their products and risk management strategies.